CY2353B1 - Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents. - Google Patents

Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents.

Info

Publication number: CY2353B1
Authority: CY; Cyprus
Prior art keywords: sugar; substituted; hypocholesterolemic agents; azetidinones useful; azetidinones
Prior art date: 1995-10-31

Application number

CY0300007A

Other languages

English (en)

Inventor

Nathan P Yumibe

Kevin B Alton

Van Margaret Heek

Harry R Davis

Wayne D Vaccaro

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-10-31

Filing date

2003-01-29

Publication date

2004-06-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26677904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2353(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-01-29 Application filed by Schering Corp filed Critical Schering Corp

2004-06-04 Publication of CY2353B1 publication Critical patent/CY2353B1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biochemistry (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Obesity (AREA)
Diabetes (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Saccharide Compounds (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

CY0300007A 1995-10-31 2003-01-29 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents. CY2353B1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US818595P	1995-10-31	1995-10-31
US57084795A	1995-12-12	1995-12-12

Publications (1)

Publication Number	Publication Date
CY2353B1 true CY2353B1 (en)	2004-06-04

Family

ID=26677904

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CY0300007A CY2353B1 (en)	1995-10-31	2003-01-29	Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents.

Country Status (27)

Country	Link
EP (1)	EP0877750B1 (fr)
JP (2)	JP3385031B2 (fr)
KR (1)	KR100311554B1 (fr)
CN (1)	CN1103780C (fr)
AR (1)	AR004701A1 (fr)
AT (1)	ATE219495T1 (fr)
AU (1)	AU712158B2 (fr)
BR (2)	BR9611401B1 (fr)
CA (1)	CA2235943C (fr)
CY (1)	CY2353B1 (fr)
CZ (1)	CZ293957B6 (fr)
DE (1)	DE69621952T2 (fr)
DK (1)	DK0877750T3 (fr)
ES (1)	ES2175141T3 (fr)
GE (1)	GEP20033006B (fr)
HU (1)	HU226822B1 (fr)
ID (1)	ID16177A (fr)
IL (1)	IL124268A (fr)
MX (1)	MX9803447A (fr)
MY (1)	MY114803A (fr)
NO (1)	NO311692B1 (fr)
NZ (1)	NZ321766A (fr)
PL (1)	PL184698B1 (fr)
PT (1)	PT877750E (fr)
SK (1)	SK283552B6 (fr)
TW (1)	TW448181B (fr)
WO (1)	WO1997016455A1 (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5633246A (en) *	1994-11-18	1997-05-27	Schering Corporation	Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
DE10042447A1 (de) *	2000-08-29	2002-03-28	Aventis Pharma Gmbh	Protein aus dem Darm von Wirbeltieren, welches Cholesterin absorbiert, sowie Verwendung dieses Proteins zur Identifizierung von Inhibitoren des intestinalen Cholesterintransports
EP1347987B1 (fr) *	2000-12-20	2004-10-13	Schering Corporation	2-azetidinones substitues par le sucre utilises comme hypocholesterolemiants
EP1510521A1 (fr) *	2000-12-20	2005-03-02	Schering Corporation	2-azetidinones substitués par le sucre utilisés comme agents hypocholestérolémiants
US6982251B2 (en)	2000-12-20	2006-01-03	Schering Corporation	Substituted 2-azetidinones useful as hypocholesterolemic agents
ES2277890T3 (es) *	2000-12-21	2007-08-01	Sanofi-Aventis Deutschland Gmbh	Nuevas difenilazetidinonas, procedimiento para su preparacion, medicamentos que contienen estos compuestos y su uso para el tratamiento de trastornos del metabolismo de lipidos.
DE10064398A1 (de) *	2000-12-21	2002-06-27	Aventis Pharma Gmbh	Neue Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
CZ20032039A3 (cs) *	2001-01-26	2004-01-14	Schering Corporation	Farmaceutický prostředek
AU2005246926B2 (en) *	2001-01-26	2008-02-28	Merck Sharp & Dohme Corp.	The use of substituted azetidinone compounds for the treatment of sitosterolemia
BRPI0206641B8 (pt) *	2001-01-26	2021-05-25	Merck Sharp & Dohme	uso de um inibidor da absorção de esteróis
SK288217B6 (sk)	2001-01-26	2014-08-05	Merck Sharp & Dohme Corp.	Zmes, terapeutická kombinácia, farmaceutický prostriedok a ich použitie
US7071181B2 (en)	2001-01-26	2006-07-04	Schering Corporation	Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
TWI291957B (en) *	2001-02-23	2008-01-01	Kotobuki Pharmaceutical Co Ltd	Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
RS50386B (sr)	2001-03-28	2009-12-31	Schering Corporation,	Enantioselektivna sinteza intermedijarnih jedinjenja azetidinona
DE60216300T2 (de)	2001-09-21	2007-06-28	Schering Corp.	Behandlung von xanthom mittels azetidinon-derivate als hemmer der sterol absorption
US7056906B2 (en)	2001-09-21	2006-06-06	Schering Corporation	Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US7053080B2 (en)	2001-09-21	2006-05-30	Schering Corporation	Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7671047B2 (en)	2002-06-19	2010-03-02	Sanofi-Aventis Deutschland Gmbh	Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
DE10227506A1 (de) *	2002-06-19	2004-01-08	Aventis Pharma Deutschland Gmbh	Ringsubstituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
US7176194B2 (en)	2002-06-19	2007-02-13	Sanofi-Aventis Deutschland Gmbh	Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
US7176193B2 (en)	2002-06-19	2007-02-13	Sanofi-Aventis Deutschland Gmbh	Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
GB0215579D0 (en)	2002-07-05	2002-08-14	Astrazeneca Ab	Chemical compounds
AR040588A1 (es)	2002-07-26	2005-04-13	Schering Corp	Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
AU2003291719A1 (en)	2002-11-06	2004-06-03	Schering Corporation	Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
CN1756756A (zh)	2003-03-07	2006-04-05	先灵公司	取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
CA2517573C (fr)	2003-03-07	2011-12-06	Schering Corporation	Composes d'azetidinone substitues, formulations et utilisations de ceux-ci pour traiter l'hypercholesterolemie
ES2311806T3 (es)	2003-03-07	2009-02-16	Schering Corporation	Compuesto de azetidinona sustituidos, fornulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
AR041089A1 (es)	2003-05-15	2005-05-04	Merck & Co Inc	Procedimiento y composiciones farmaceutiicas para tratar aterosclerosis, dislipidemias y afecciones relacionadas
JP2005015434A (ja)	2003-06-27	2005-01-20	Kotobuki Seiyaku Kk	血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
EP1522541A1 (fr) *	2003-10-07	2005-04-13	Lipideon Biotechnology AG	Nouveaux composés hypocholesterolémiques
JP2007509963A (ja) *	2003-10-30	2007-04-19	メルク　エンド　カムパニー　インコーポレーテッド	抗高コレステロール血漿薬としての２−アゼチジノン
ATE485267T1 (de)	2003-12-23	2010-11-15	Astrazeneca Ab	Diphenylazetidinonderivate mit die cholesterinabsorption hemmender wirkung
US20060211752A1 (en)	2004-03-16	2006-09-21	Kohn Leonard D	Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
JP2008539255A (ja) *	2005-04-26	2008-11-13	マイクロビアインコーポレーテッド	高コレステロール血症のための４−ビアリーリル−１−フェニルアゼチジン−２−オングルクロニド誘導体
SA06270191B1 (ar)	2005-06-22	2010-03-29	استرازينيكا ايه بي	مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
AU2006304836A1 (en)	2005-10-21	2007-04-26	Novartis Ag	Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent
TW200811098A (en)	2006-04-27	2008-03-01	Astrazeneca Ab	Chemical compounds
US20080319221A1 (en)	2007-06-22	2008-12-25	Bernd Junker	Esters of Pentahydroxyhexylcarbamoyl Alkanoic Acids
DE102007054497B3 (de)	2007-11-13	2009-07-23	Sanofi-Aventis Deutschland Gmbh	Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung
WO2010100255A1 (fr)	2009-03-06	2010-09-10	Lipideon Biotechnology Ag	Compositions pharmaceutiques hypocholestérolémiques
CN101993403B (zh)	2009-08-11	2012-07-11	浙江海正药业股份有限公司	氮杂环丁酮类化合物及医药应用
CN103102297A (zh) *	2012-09-28	2013-05-15	北京赛林泰医药技术有限公司	一种新的依折麦布的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
LT3595B (en)	1993-01-21	1995-12-27	Schering Corp	Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents
CA2120221A1 (fr) *	1993-04-23	1994-10-24	Allan W. Rey	2-azetidinones substituees en n
US5631365A (en) *	1993-09-21	1997-05-20	Schering Corporation	Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US5627176A (en)	1994-03-25	1997-05-06	Schering Corporation	Substituted azetidinone compounds useful as hypocholesterolemic agents
US5633246A (en)	1994-11-18	1997-05-27	Schering Corporation	Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents

1996
- 1996-10-29 CZ CZ19981294A patent/CZ293957B6/cs not_active IP Right Cessation
- 1996-10-29 TW TW085113142A patent/TW448181B/zh not_active IP Right Cessation
- 1996-10-29 SK SK483-98A patent/SK283552B6/sk not_active IP Right Cessation
- 1996-10-29 DE DE69621952T patent/DE69621952T2/de not_active Expired - Lifetime
- 1996-10-29 BR BRPI9611401-0A patent/BR9611401B1/pt not_active IP Right Cessation
- 1996-10-29 MY MYPI96004488A patent/MY114803A/en unknown
- 1996-10-29 AT AT96937702T patent/ATE219495T1/de active
- 1996-10-29 KR KR1019980703155A patent/KR100311554B1/ko not_active Expired - Fee Related
- 1996-10-29 AR ARP960104954A patent/AR004701A1/es not_active Application Discontinuation
- 1996-10-29 HU HU9802539A patent/HU226822B1/hu unknown
- 1996-10-29 JP JP51738697A patent/JP3385031B2/ja not_active Expired - Fee Related
- 1996-10-29 PL PL96327987A patent/PL184698B1/pl not_active IP Right Cessation
- 1996-10-29 DK DK96937702T patent/DK0877750T3/da active
- 1996-10-29 CA CA002235943A patent/CA2235943C/fr not_active Expired - Lifetime
- 1996-10-29 IL IL12426896A patent/IL124268A/xx not_active IP Right Cessation
- 1996-10-29 NZ NZ321766A patent/NZ321766A/xx not_active IP Right Cessation
- 1996-10-29 CN CN96199226A patent/CN1103780C/zh not_active Expired - Lifetime
- 1996-10-29 ES ES96937702T patent/ES2175141T3/es not_active Expired - Lifetime
- 1996-10-29 EP EP96937702A patent/EP0877750B1/fr not_active Expired - Lifetime
- 1996-10-29 GE GEAP19966589A patent/GEP20033006B/en unknown
- 1996-10-29 PT PT96937702T patent/PT877750E/pt unknown
- 1996-10-29 BR BRPI9612998-0A patent/BR9612998B1/pt not_active IP Right Cessation
- 1996-10-29 WO PCT/US1996/016823 patent/WO1997016455A1/fr not_active Ceased
- 1996-10-29 AU AU75179/96A patent/AU712158B2/en not_active Ceased
- 1996-10-30 ID IDP963136A patent/ID16177A/id unknown
1998
- 1998-04-29 NO NO19981950A patent/NO311692B1/no not_active IP Right Cessation
- 1998-04-30 MX MX9803447A patent/MX9803447A/es unknown
2000
- 2000-07-17 JP JP2000216704A patent/JP2001048895A/ja not_active Withdrawn
2003
- 2003-01-29 CY CY0300007A patent/CY2353B1/xx unknown

Also Published As

Publication number	Publication date
HK1012507A1 (en)	1999-08-06
CA2235943A1 (fr)	1997-05-09
AR004701A1 (es)	1999-03-10
CZ129498A3 (cs)	1998-10-14
EP0877750A1 (fr)	1998-11-18
AU7517996A (en)	1997-05-22
SK283552B6 (sk)	2003-09-11
SK48398A3 (en)	1998-11-04
EP0877750B1 (fr)	2002-06-19
NO981950D0 (no)	1998-04-29
PL184698B1 (pl)	2002-12-31
MX9803447A (es)	1998-09-30
DK0877750T3 (da)	2002-07-15
NO981950L (no)	1998-06-26
BR9612998B1 (pt)	2010-03-23
PL327987A1 (en)	1999-01-04
ID16177A (id)	1997-09-11
CN1103780C (zh)	2003-03-26
PT877750E (pt)	2002-09-30
CN1205707A (zh)	1999-01-20
HUP9802539A3 (en)	1999-12-28
AU712158B2 (en)	1999-10-28
JPH10512592A (ja)	1998-12-02
BR9611401A (pt)	1999-01-05
KR19990067202A (ko)	1999-08-16
HU226822B1 (en)	2009-11-30
ES2175141T3 (es)	2002-11-16
CA2235943C (fr)	2002-10-01
KR100311554B1 (ko)	2002-06-20
DE69621952D1 (de)	2002-07-25
WO1997016455A1 (fr)	1997-05-09
NZ321766A (en)	1999-07-29
BR9611401B1 (pt)	2010-08-10
NO311692B1 (no)	2002-01-07
CZ293957B6 (cs)	2004-08-18
DE69621952T2 (de)	2003-01-16
TW448181B (en)	2001-08-01
ATE219495T1 (de)	2002-07-15
JP3385031B2 (ja)	2003-03-10
JP2001048895A (ja)	2001-02-20
GEP20033006B (en)	2003-07-10
HUP9802539A2 (hu)	1998-11-30
IL124268A (en)	2005-08-31
MY114803A (en)	2003-01-31

Publication	Publication Date	Title
CY2353B1 (en)	2004-06-04	Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents.
AU2943095A (en)	1996-01-15	Substituted azetidinone compounds useful as hypocholesterolemic agents
ZA9610858B (en)	1998-06-23	Heteroclyclic compounds.
FI953497A7 (fi)	1995-07-20	Spirosykloalkyylisubstituoidut atsetidinonit, jotka ovat käyttökelpoisia hypokolesteroleemisina aineina
ZA967315B (en)	1998-03-02	Biphenylamides.
FI972099A7 (fi)	1997-05-16	Rikki-substituoidut atsetidinoniyhdisteet, jotka ovat hyödyllisiä hypokolesteroeemisinä aineina
ZA965934B (en)	1997-02-03	Chemical compounds.
MX213417B (es)	2003-03-27	Fenilpiridazinonas.
ZA964715B (en)	1997-12-08	Raman Microscope.
ZA965505B (en)	1998-03-30	Novel compounds.
ZA966245B (en)	2000-04-25	Examining a diamond.
ZA985875B (en)	2000-01-10	Azetidines.
ZA961955B (en)	1997-09-11	Indazolecarboxamides.
ZA962277B (en)	1997-09-22	Cutting mechanism.
DE69610844D1 (en)	2000-12-07	Hydroformylierungsverfahren.
ZA967503B (en)	1997-09-05	Barriers.
GB9524180D0 (en)	1996-01-31	Hammer mechanism
ZA964560B (en)	1997-12-03	Anit-viral compounds.
ZA966399B (en)	1997-02-19	Endothelin-receptor-antagonists.
ZA963787B (en)	1997-11-13	Antibiotics.
ZA966750B (en)	1997-02-18	Halogenobenzimidazoles.
ZA966933B (en)	1997-02-19	Endothelin-receptor-antagonists.
ZA967314B (en)	1998-03-02	Carbamoylcarboxamides.
ZA969089B (en)	1997-04-29	Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
ZA969560B (en)	1998-05-14	Substituted 1-methyl-3-phenylpyrazoles.